Galmed Pharmaceuticals (GLMD) Revenue (2016 - 2018)
Galmed Pharmaceuticals (GLMD) posted quarterly Revenue of $1.5 million for Q3 2018, up 449.45% year-over-year from $273000.0 in Q3 2017, and up 455.56% quarter-over-quarter from $270000.0 in Q2 2018.
Galmed Pharmaceuticals (GLMD) Revenue (2016 - 2018) Analysis & Trends
Galmed Pharmaceuticals' Revenue history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2018.
- In Q3 2018, Revenue rose 449.45% year-over-year to $1.5 million; the TTM figure through Jun 2019 stood at $1.8 million (up 63.13% YoY), while the FY2018 annual figure was $2.0 million, up 87.83% from the prior year.
- Revenue for Q3 2018 stood at $1.5 million, up from $270000.0 in the prior quarter.
- The five-year high for Revenue was $1.5 million in Q3 2018, with the low at $193000.0 in Q3 2016.
- The 3-year median for Revenue is $270000.0 (2017), against an average of $398888.9.
- The sharpest annual moves came in 2017 and 2018: Revenue changed 0.0% in 2017, then soared 449.45% in 2018.
- Galmed Pharmaceuticals' Revenue stood at $274000.0 in 2016, then changed by 0.0% to $274000.0 in 2017, then soared by 447.45% to $1.5 million in 2018.
- Business Quant data shows GLMD's Revenue at $1.5 million in Q3 2018, $270000.0 in Q2 2018, and $268000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 1.50 Mn |
| Jun 30, 2018 | 270,000.00 |
| Mar 31, 2018 | 268,000.00 |
| Dec 31, 2017 | 274,000.00 |
| Sep 30, 2017 | 273,000.00 |
| Jun 30, 2017 | 270,000.00 |
| Mar 31, 2017 | 268,000.00 |
| Dec 31, 2016 | 274,000.00 |
| Sep 30, 2016 | 193,000.00 |